1. Efficacy and Safety of Oral NEPA (Netupitant/Palonosetron), the First Fixed-Combination Antiemetic, in Patients With Gynecological Cancers Receiving Platinum-Based Chemotherapy. Issue 6 (1st June 2018) Authors: Bošnjak, Snežana M.; Stamatovic, Ljiljana; Borroni, Maria Elisa; Rizzi, Giada; Jordan, Karin Journal: International journal of gynecological cancer Issue: Volume 28:Issue 6(2018) Page Start: 1153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and Safety of Oral NEPA (Netupitant/Palonosetron), the First Fixed-Combination Antiemetic, in Patients With Gynecological Cancers Receiving Platinum-Based Chemotherapy. Issue 6 (July 2018) Authors: Bošnjak, Snežana M.; Stamatovic, Ljiljana; Borroni, Maria Elisa; Rizzi, Giada; Jordan, Karin Journal: International journal of gynecological cancer Issue: Volume 28:Issue 6(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy of NEPA (netupitant/palonosetron) across multiple cycles of chemotherapy in breast cancer patients: A subanalysis from two phase III trials. (June 2017) Authors: Rugo, Hope S.; Rossi, Giorgia; Rizzi, Giada; Aapro, Matti Journal: Breast Issue: Volume 33(2017) Page Start: 76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Fixed combination of oral NEPA (netupitant‐palonosetron) for the prevention of acute and delayed chemotherapy‐induced nausea and vomiting in patients receiving multiple cycles of chemotherapy: Efficacy data from 2 randomized, double‐blind phase III studies. (9th April 2019) Authors: Schwartzberg, Lee; Karthaus, Meinolf; Rossi, Giorgia; Rizzi, Giada; Borroni, Maria E.; Rugo, Hope S.; Jordan, Karin; Hansen, Vincent Journal: Cancer medicine Issue: Volume 8:Number 5(2019:May) Page Start: 2064 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Phase IIIb Safety and Efficacy of Intravenous NEPA for Prevention of Chemotherapy‐Induced Nausea and Vomiting (CINV) in Patients with Breast Cancer Receiving Initial and Repeat Cycles of Anthracycline and Cyclophosphamide (AC) Chemotherapy. (8th December 2019) Authors: Schwartzberg, Lee; Navari, Rudolph; Clark‐Snow, Rebecca; Arkania, Ekaterine; Radyukova, Irena; Patel, Kamal; Voisin, Daniel; Rizzi, Giada; Wickham, Rita; Gralla, Richard J.; Aapro, Matti; Roeland, Eric Journal: Oncologist Issue: Volume 25:Number 3(2020) Page Start: e589 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PO112EFFICACY OF NEPA, THE FIRST COMBINATION ANTIEMETIC AGENT, IN PATIENTS WITH BREAST CANCER RECEIVING ANTHRACYCLINE/CYCLOPHOSPHAMIDE (AC) OR NON-AC CHEMOTHERAPY. (November 2015) Authors: Rugo, Hope; Aapro, Matti; Rossi, Giorgia; Rizzi, Giada Journal: Breast Issue: Volume 24(2015)Supplement 3 Page Start: S60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Safety and efficacy of NEPA, an oral fixed combination of netupitant and palonosetron, in older patients. Issue 1 (January 2017) Authors: Aapro, Matti; Jordan, Karin; Gralla, Richard J.; Rizzi, Giada; Rossi, Giorgia; Palmas, Marco; Alyasova, Anna V.; Lisyanskaya, Alla S.; Bošnjak, Snežana M.; Hesketh, Paul J. Journal: Journal of geriatric oncology Issue: Volume 8:Issue 1(2017) Page Start: 56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Safety of an Oral Fixed Combination of Netupitant and Palonosetron (NEPA): Pooled Data From the Phase II/III Clinical Program. (21st March 2016) Authors: Aapro, Matti; Hesketh, Paul J.; Jordan, Karin; Gralla, Richard J.; Rossi, Giorgia; Rizzi, Giada; Palmas, Marco Journal: Oncologist Issue: Volume 21:Number 4(2016) Page Start: 494 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗